Royalty Pharma plc

RPRX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $22.4B · 100 employees
110
SEC Filings
$55.76
Close 2026-05-29
100
Employees

Business Summary

PART I Overview We are the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry. Since our founding in 1996, we have been pioneers in the royalty market, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. We have assembled a portfolio of royalties which entitles us to payments based directly on...

Latest Stock Quote

RPRX 2026-05-29 $55.76 O:$54.48 H:$56.07 L:$54.31 Vol:18.0M VWAP:$55.6119
origin leaf: e77d6badb2acfc8b6ff3862472bcfba420404d08b9af61a07bfca7d8d59291c2

Next Earnings

Q2 FY2026 — expected 2026-09-15

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-112025-12-310001802768-26-000003EDGAR77K words
2025-02-122024-12-310001802768-25-000010EDGAR—
2024-02-152023-12-310001802768-24-000012EDGAR—
2023-02-152022-12-310001802768-23-000007EDGAR—
2022-02-152021-12-310001802768-22-000011EDGAR—
2021-02-242020-12-310001802768-21-000006EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001802768-25-000114EDGAR59K words
2025-08-062025-06-300001802768-25-000095EDGAR—
2025-05-082025-03-310001802768-25-000027EDGAR—
2024-11-062024-09-300001802768-24-000058EDGAR—
2024-08-082024-06-300001802768-24-000045EDGAR—
2024-05-092024-03-310001802768-24-000021EDGAR—
2023-11-082023-09-300001802768-23-000029EDGAR—
2023-08-082023-06-300001802768-23-000023EDGAR—
2023-05-092023-03-310001802768-23-000015EDGAR—
2022-11-082022-09-300001802768-22-000045EDGAR—
2022-08-042022-06-300001802768-22-000035EDGAR—
2022-05-052022-03-310001802768-22-000020EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-110001802768-26-000002EDGAR7K words
2025-12-220001193125-25-328759EDGAR—
2025-12-220001193125-25-328100EDGAR—
2025-11-050001802768-25-000113EDGAR—
2025-09-160001193125-25-204983EDGAR—
2025-08-130001193125-25-179892EDGAR—
2025-08-060001193125-25-173988EDGAR—
2025-07-170001193125-25-160293EDGAR—
2025-05-190000950103-25-006186EDGAR—
2025-05-120001193125-25-117771EDGAR—

110 total filings indexed. 82 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001802768
TickerRPRX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedX0
Websitehttps://www.royaltypharma.com
Listed2020-06-16

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f716e6aed5458d2fab7fdfc3f4fd4b46ca39564bad30d3bf363702e161dacf5d
parent: a804f5f78f5395c521ccad38ee17a3689747f7d91613a52cf8a446b581ef7ac5
content hash: 5a4946ba96519539ff94410bb048fcd0e67a710ef40d9639c962eddb43a3b4d4
signed: 2026-06-03T12:02:27.599Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf